3 terminated. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Terminated 3 |
Follow Intraabdominal Infections: new trials by email Literature Review of Intraabdominal Infections trials Research Report on Intraabdominal Infections
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| LYS228 PK, Clinical Response, Safety and Tolerability in Patients With Complicated Intra-abdominal Infection (cIAI) LYS228, Standard of care therapy - Intra-abdominal Infections | Phase 2 | Terminated | Novartis Pharmaceuticals | 3 | 2018-05-15 | 2021-10-11 |
| Transversus Abdominis Plane (TAP) Versus Local Anesthetic for Lap Appendectomies Ropivacaine, Bupivacaine - Appendicitis | Phase 2 | Terminated | Nationwide Children's Hospital | 3 | 2012-10-01 | 2015-08-24 |
| GSK2251052 in the Treatment of Complicated Intra-abdominal Infections Drug: GSK2251052, Meropenem, Placebo - Infections, Intestinal | Phase 2 | Terminated | GlaxoSmithKline | 15 | 2011-10-03 | 2017-11-29 |
Abscess (1) · Appendicitis (1) · Infections (1) · Peritonitis (1)
Digestive System Diseases (2) · Infections (2) · Cecal Diseases (1) · Gastroenteritis (1) · Gastrointestinal Diseases (1) · Inflammation (1) · Intestinal Diseases (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Peritoneal Diseases (1) · Suppuration (1)
3-(aminomethyl)-7-(3-hydroxypropoxy)-1-hydroxy-1,3-dihydro-2,1-benzoxaborole (1) · Bupivacaine (1) · Meropenem (1) · Ropivacaine (1)
GlaxoSmithKline (1) · Nationwide Children's Hospital (1) · Novartis Pharmaceuticals (1)
United States (3) · Canada (1) · Czechia (1) · France (1) · Italy (1) · Russia (1) · Spain (1)
Tarun Bhalla, MD (1)